
Insulet Corporation PODD
$ 224.66
0.0%
Quarterly report 2025-Q3
added 03-14-2026
Insulet Corporation Shares 2011-2026 | PODD
Annual Shares Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.3 M | 70.1 M | 69.8 M | 69.4 M | 67.7 M | 64.7 M | 60.6 M | 58.9 M | 58 M | 57.3 M | 56.8 M | 55.6 M | 54 M | 47.9 M | 46.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.3 M | 46.7 M | 60.5 M |
Quarterly Shares Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.4 M | 70.4 M | 70.3 M | 70.2 M | 70.1 M | 70.1 M | 70 M | 69.9 M | 69.8 M | 69.7 M | 69.6 M | 69.5 M | 69.4 M | 69.4 M | 69.3 M | 69.2 M | 68.9 M | 66.7 M | 66.1 M | 66 M | 65.9 M | 65.6 M | 62.9 M | 62.7 M | 60.7 M | 59.8 M | 59.4 M | 59.2 M | 59 M | 58.8 M | 58.5 M | 58.3 M | 58.1 M | 58 M | 57.7 M | 57.5 M | 57.3 M | 57.2 M | 57 M | 57 M | 56.9 M | 56.8 M | 56.5 M | 56.3 M | 55.8 M | 55.4 M | 55.1 M | 54.9 M | 54.5 M | 53.8 M | 53.1 M | 48.4 M | 48 M | 47.8 M | 47.6 M | 47.5 M | 47.3 M | 46.4 M | 47.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 70.4 M | 46.4 M | 60.4 M |
Shares of other stocks in the Medical devices industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
1.56 M | $ 2.11 | - | $ 3.29 M | ||
|
AdaptHealth Corp.
AHCO
|
135 M | $ 10.42 | - | $ 1.41 B | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Butterfly Network
BFLY
|
212 M | $ 3.91 | - | $ 828 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
67.5 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
29.1 M | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
17.8 M | - | 24.59 % | $ 44.8 M | ||
|
CONMED Corporation
CNMD
|
31 M | $ 37.41 | - | $ 1.16 B | ||
|
Alphatec Holdings
ATEC
|
150 M | $ 12.6 | - | $ 1.89 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
7.77 M | - | -5.86 % | $ 30.6 M | ||
|
Cognyte Software Ltd.
CGNT
|
71.8 M | $ 8.38 | - | $ 602 M | ||
|
Aziyo Biologics
AZYO
|
41.4 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
37.3 M | $ 3.96 | 1.02 % | $ 148 M | ||
|
Avinger
AVGR
|
786 K | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
1.28 M | - | -13.19 % | $ 166 K | ||
|
Boston Scientific Corporation
BSX
|
1.48 B | $ 69.79 | - | $ 103 B | ||
|
Establishment Labs Holdings
ESTA
|
29.6 M | $ 63.48 | - | $ 1.88 B | ||
|
Conformis
CFMS
|
7.22 M | - | - | $ 16.4 M | ||
|
Apollo Endosurgery
APEN
|
40.7 M | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
608 K | $ 2.19 | - | $ 1.33 M | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.65 | -8.13 % | $ 35.4 M | ||
|
Cutera
CUTR
|
19.9 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
37.9 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
8.13 M | - | 14.99 % | $ 929 K | ||
|
IRIDEX Corporation
IRIX
|
16.1 M | $ 1.33 | - | $ 21.5 M | ||
|
ClearPoint Neuro
CLPT
|
27 M | $ 11.03 | - | $ 298 M | ||
|
CHF Solutions, Inc.
CHFS
|
81.1 K | - | 1.15 % | $ 34.5 M | ||
|
Axonics Modulation Technologies
AXNX
|
46.7 M | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
21.1 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
859 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
13.8 M | - | 0.03 % | $ 1.58 B | ||
|
LivaNova PLC
LIVN
|
54.5 M | $ 61.43 | - | $ 3.35 B | ||
|
Misonix, Inc.
MSON
|
14.7 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
63 M | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
6.55 M | $ 18.42 | 0.22 % | $ 121 M | ||
|
InMode Ltd.
INMD
|
64.6 M | $ 13.43 | - | $ 868 M | ||
|
MiMedx Group
MDXG
|
148 M | $ 4.41 | - | $ 652 M | ||
|
GBS
GBS
|
5.27 M | - | -0.57 % | $ 7.12 M | ||
|
Intersect ENT, Inc.
XENT
|
32.7 M | - | - | $ 955 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
58.7 M | $ 2.59 | - | $ 152 M | ||
|
Abbott Laboratories
ABT
|
1.74 B | $ 109.95 | - | $ 191 B | ||
|
Delcath Systems
DCTH
|
35.8 M | $ 9.81 | - | $ 351 M | ||
|
Bio-Rad Laboratories
BIO
|
28.2 M | $ 261.24 | - | $ 7.37 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
77 M | $ 9.01 | - | $ 694 M | ||
|
Profound Medical Corp.
PROF
|
20.5 M | $ 5.71 | - | $ 180 M | ||
|
AxoGen
AXGN
|
46.1 M | $ 32.84 | - | $ 1.51 B | ||
|
Align Technology
ALGN
|
74.9 M | $ 169.45 | - | $ 12.7 B | ||
|
Bruker Corporation
BRKR
|
149 | $ 32.76 | - | $ 4.88 K | ||
|
AVITA Medical
RCEL
|
27.9 M | $ 4.62 | 5.0 % | $ 129 M |